Document Detail


Hemodynamic effect of calcium channel blockade during anesthesia for coronary artery surgery.
MedLine Citation:
PMID:  1498296     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Because the choice of anesthetic technique does not influence the incidence of perioperative myocardial ischemia, reduction of ischemic risk may require specific antianginal therapy. Calcium entry blockers are effective drugs in antianginal therapy. Diltiazem reduces myocardial oxygen demand through decreases in heart rate, inotropy, and systolic function, while increasing myocardial oxygen delivery through coronary vasodilation. These potentially beneficial effects of diltiazem were evaluated in 15 of 29 patients (diltiazem v placebo, double-blind study) scheduled for coronary artery bypass graft surgery. Continuous infusion of diltiazem (0.15 mg/kg bolus followed by 2 micrograms/kg/min), during anesthesia and surgery before cardiopulmonary bypass, significantly reduced the major MVO2 determinants during anesthesia with moderate doses of fentanyl and a benzodiazepine (midazolam in 8 of 14 control patients and 9 of 15 treated patients, or flunitrazepam in the others). Heart rate, mean arterial pressure, and inotropy were decreased during the most stressful events of surgery when plasma diltiazem concentrations were in the therapeutic range (greater than 96 ng/mL). The number of patients with perioperative ischemia was 2 of 15 in the treated group and 4 of 14 in the control group. Provided that diltiazem plasma concentrations are sufficient, it can contribute to lowering the ischemic burden during anesthesia for coronary artery surgery.
Authors:
P Colson; P Médioni; M Saussine; J R Séguin; D Cuchet; D Grolleau; P A Chaptal; B Roquefeuil
Related Documents :
10861156 - Analysis of risk factors for myocardial infarction and cardiac mortality after major va...
2094696 - Mortality in the first year after coronary artery bypass surgery. irish cardiac surgery...
9357346 - Are the best coronary artery bypass surgeons identified by physician surveys?
12062176 - Development and evaluation of a novel decellularized vascular xenograft.
8851246 - Ambulatory monitoring of the impedance cardiogram.
20861416 - Nitrous oxide and long-term morbidity and mortality in the enigma trial.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of cardiothoracic and vascular anesthesia     Volume:  6     ISSN:  1053-0770     ISO Abbreviation:  J. Cardiothorac. Vasc. Anesth.     Publication Date:  1992 Aug 
Date Detail:
Created Date:  1992-09-11     Completed Date:  1992-09-11     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9110208     Medline TA:  J Cardiothorac Vasc Anesth     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  424-8     Citation Subset:  IM    
Affiliation:
Department of Anesthesiology, St-Eloi Hospital, Montpellier, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anesthesia, Intravenous
Blood Pressure / drug effects
Cardiac Output / drug effects
Cardiopulmonary Bypass
Coronary Artery Bypass* / adverse effects
Coronary Disease / prevention & control*
Diltiazem / blood,  therapeutic use*
Double-Blind Method
Droperidol
Fentanyl
Flunitrazepam
Heart Rate / drug effects
Hemodynamics / drug effects
Humans
Incidence
Intraoperative Complications / prevention & control*
Midazolam
Middle Aged
Placebos
Pulmonary Wedge Pressure / drug effects
Time Factors
Vascular Resistance / drug effects
Chemical
Reg. No./Substance:
0/Placebos; 1622-62-4/Flunitrazepam; 42399-41-7/Diltiazem; 437-38-7/Fentanyl; 548-73-2/Droperidol; 59467-70-8/Midazolam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anesthesia for bilateral lung transplantation without cardiopulmonary bypass: initial experience and...
Next Document:  Prognostic value of biventricular function in hypotensive patients after cardiac surgery as assessed...